Word

SYNVANTAGE

Status

Registered

Status Code

700

Status Date

Tuesday, July 23, 2024

Serial Number

90100048

Registration Number

7452470

Registration Date

Tuesday, July 23, 2024

Mark Type

4

Filing Date

Friday, August 7, 2020

Published for Opposition

Tuesday, May 7, 2024

Trademark Owner History

Syngene International Limited - Original Registrant

Classifications

5 Autonomic drugs for medical purposes for treatment of diseases and conditions in the fields of oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Diagnostic preparations for medical or veterinary purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for treating diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Dietary supplements for humans and animals; Biological tissue cultures for medical purposes; Biological preparations for the treatment of diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Pharmaceutical preparations for the treatment of infectious diseases; Bio-logical and biotechnological products pertaining to pharmaceutical and medical industries and formulations thereof for pharmaceutical and medical use, namely, pharmaceutical preparations for the treatment of diseases and conditions in the fields of oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; synthetic peptides for pharmaceutical purposes and for the treatment of diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; imaging agents for magnetic resonance imaging (MRI); nucleic acid sequences and chemical reagents for medical and veterinary purposes; pharmaceutical preparations and substances for the treatment of diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; biological tissue grafts; vascular grafts comprised of living tissue; biopharmaceuticals for the treatment of cancer; yeast and yeast extracts for medical, veterinary or pharmaceutical purposes; Protein arrays for medical diagnosis purposes; medicines for veterinary purposes for the treatment of skin allergies, ehrlichiosis, ear infection, diabetes, kennel cough, upper respiratory tract infection, coccidiosis, babesiosis, ectoparasites, endoparasites; isotopes for medical purposes; chemical preparations for medical purposes for use in DNA analysis; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Contrast media for in vivo imaging; Contrast agents for use in molecular imaging

1 Chemicals for use in biotechnological manufacturing processes and product development; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Chemicals for use in industry and science; Biological preparations for use in industry and science; Enzymes derived from biotechnological processes for use in industry; enzyme substrates; enzyme stabilizers; Enzymes for scientific and research purposes; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory, research, clinical or medical laboratory use; chitosans for industrial purposes; aldehydes; chromatography chemicals; Stem cells for research purposes; cells for scientific, laboratory or medical research; Reagents for scientific and research use; nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; nucleotides for scientific and research use; Protein for industrial use; Proteins for use in manufacture; specialty chemicals, namely, chemical additives for general industrial use in the manufacture of a wide variety of goods; chemical reference standards for use in science and industry; isotopes for industrial purposes; biochemicals for in vitro and in vivo scientific use; Nucleic acid sequences, other than for medical or veterinary purposes; Reagents for scientific purposes for use in nucleic acid isolation and purification; gels, reagents, chemical standards, dyes and trace dyes for electrophoresis, other than for medical or veterinary purposes; preparative electrophoresis reagents, other than for medical or veterinary purposes

44 Drug, alcohol and DNA screening for medical purposes; medical services; medical and pharmaceutical consultation; Medical diagnostic testing, monitoring and reporting services; pathology services for medical and diagnostic purposes

42 Development of pharmaceutical preparations and medicines; Drug discovery services; Pharmaceutical drug development services; Scientific study and research in the fields of medicine, the prevention, treatment and management of illness, health care delivery; medical research services; pharmaceutical research services; laboratory research services relating to pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Conducting clinical trials for others; biological and chemical research; bacteriological research; Biological research and analysis; custom design and development of chemical reagents and biochemical assays; laboratory testing services for research and development purposes; testing of pharmaceuticals; chemical engineering; scientific study and research in the field of reproduction, husbandry, and general health of animal; biotechnology research for determining the neuronal survival of molecules in animal models; research and development services in the field of antibodies, antibody technology, immunopharmaceuticals and vaccines; design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; toxicology services; toxicity testing for research purposes; conducting clinical trials for others in the field of pharmaceutical products; providing medical and scientific research information in the field of clinical trials; conducting early evaluations in the field of new pharmaceuticals; DNA analysis services for scientific research purposes; laboratory research in the field of gene expression; blood analysis services for scientific research purposes; analysis of human tissues for medical research; scientific services relating to the isolation and cultivation of human tissues and cells for research purposes; preparation of reports relating to scientific and technical research; analysis in the field of molecular biology; contract scientific research services relating to molecular sciences; biological cloning services; structural and functional analysis of genomes; scientific and medical laboratory services; services of a chemical and biological laboratory for research purposes; research and development and consultation related thereto in the field of antibodies, antibody technology, chemistry, agrochemical pharmaceuticals, bioinformatics, biomedical devices, biologics, biotechnology, biotherapeutics, biology, biochemical preparations, cell lines, chemoinformatic, genetics and genetic engineering, gene expression systems, in vitro research, inhalation pharmaceuticals, molecular sciences, micro organisms, nutrition, ophthalmic preparations, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymers, peptide synthesis, protein, and solid state characterization; scientific and technological services, namely, scientific research, development, analysis, testing, and technological services, namely, scientific research, development, analysis, testing, engineering, extraction, synthesis, purification and production in the field of antibodies, active pharmaceutical ingredients (API), biomolecules, cell bank characterization, chirality, chromosome aberration, clinical chemistry, cloning vector, cyclotides, DNA, flow cytometry, gas chromatography mass spectrometry, gene, immuno-pharmaceuticals, in vitro irritation, large molecule, liquid chromatography mass spectrometry, microbials, monomers, nanoparticles, natural products, peptides, proteins, RNA, supercritical fluid chromatography, small molecules and vaccines; Laboratory services, namely, imaging core lab services

Trademark Events

Aug 11, 2020

New Application Entered

Sep 9, 2020

New Application Office Supplied Data Entered

Nov 4, 2020

Assigned To Examiner

Nov 10, 2020

Non-Final Action Written

Nov 10, 2020

Non-Final Action E-Mailed

Nov 10, 2020

Notification Of Non-Final Action E-Mailed

Mar 4, 2021

Examiners Amendment -Written

Mar 4, 2021

Examiners Amendment E-Mailed

Mar 4, 2021

Notification Of Examiners Amendment E-Mailed

Mar 4, 2021

Examiner's Amendment Entered

Mar 4, 2021

Approved For Pub - Principal Register

Mar 17, 2021

Notification Of Notice Of Publication E-Mailed

Apr 6, 2021

Published For Opposition

Apr 6, 2021

Official Gazette Publication Confirmation E-Mailed

Jun 1, 2021

Noa E-Mailed - Sou Required From Applicant

Nov 30, 2021

Sou Teas Extension Received

Nov 30, 2021

Sou Extension 1 Filed

Nov 30, 2021

Sou Extension 1 Granted

Dec 2, 2021

Notice Of Approval Of Extension Request E-Mailed

May 31, 2022

44(E) Petition - Received

May 31, 2022

Teas Petition To Amend Basis Received

Jun 1, 2022

Sou Extension 2 Filed

Jun 22, 2022

Assigned To Petition Staff

Jul 4, 2022

Abandonment - No Use Statement Filed

Jul 5, 2022

Abandonment Notice E-Mailed - No Use Statement Filed

Jul 6, 2022

Sou Extension Received With Teas Petition

Jul 8, 2022

Petition Granted - Extension Request Filed

Jul 8, 2022

Sou Extension 2 Granted

Jul 8, 2022

Assigned To Petition Staff

Jul 8, 2022

Petition To Director - Change Basis - Granted

Jul 8, 2022

Attorney Review/Decision On Amendment Required

Jul 8, 2022

Notice Of Revival - E-Mailed

Jul 9, 2022

Notice Of Approval Of Extension Request E-Mailed

Jul 20, 2022

Assigned To Examiner

Jul 29, 2022

Attorney Review Completed

Sep 30, 2022

Teas Post Publication Amendment Received

Sep 30, 2022

44(E) Petition - Received

Oct 20, 2022

Case Assigned To Intent To Use Paralegal

Oct 20, 2022

Review Of Correspondence Complete

Nov 30, 2022

Sou Teas Extension Received

Nov 30, 2022

Sou Extension 3 Filed

Nov 30, 2022

Sou Extension 3 Granted

Dec 2, 2022

Notice Of Approval Of Extension Request E-Mailed

Jun 1, 2023

Sou Teas Extension Received

Jun 1, 2023

Sou Extension 4 Filed

Jun 1, 2023

Sou Extension 4 Granted

Jun 3, 2023

Notice Of Approval Of Extension Request E-Mailed

Dec 1, 2023

Sou Teas Extension Received

Dec 1, 2023

Sou Extension 5 Filed

Dec 4, 2023

Sou Extension 5 Granted

Dec 5, 2023

Notice Of Approval Of Extension Request E-Mailed

Apr 1, 2024

Petition To Director - Change Basis - Granted

Mar 5, 2024

Assigned To Petition Staff

Mar 6, 2024

Petition Inquiry Letter Issued

Mar 27, 2024

Teas Response To Petition Inquiry Letter

Apr 1, 2024

Jurisdiction Restored To Examining Attorney

Apr 3, 2024

Notice Of Allowance Cancelled

Apr 3, 2024

Case Returned To Examination

Apr 3, 2024

Attorney Review Completed

Apr 17, 2024

Notification Of Notice Of Publication E-Mailed

May 7, 2024

Published For Opposition

May 7, 2024

Official Gazette Publication Confirmation E-Mailed

Jul 23, 2024

Registered-Principal Register

Jul 23, 2024

Notice Of Registration Confirmation Emailed